Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Footer changes include the addition of 'Revision: v3.3.3' and removal of the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' entry. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T07:37:12.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page header, indicating a minor site update.
    Difference
    0.1%
    Check dated 2025-12-01T16:47:15.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:43:31.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding and NIH operating status. The banner previously informed users that data may be delayed and directed users to cc.nih.gov and opm.gov for updates.
    Difference
    0.4%
    Check dated 2025-11-17T06:24:04.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    New version entries appear in the Record History, reflecting ongoing updates to the study record (e.g., Study Status and Contacts/Locations), while the overall page structure remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:08:15.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    9%
    Check dated 2025-10-05T10:06:16.000Z thumbnail image

Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.